SVR12 OF 99% ACHIEVED WITH A RIBAVIRIN-FREE REGIMEN OF ABT-450/R/OMBITASVIR AND DASABUVIR IN HCV GENOTYPE 1B-INFECTED PATIENTS

Andreas Maieron  1     Massimo Puoti  2     Jeffrey Enejosa  3     Ziv Ari  4     Gunnar Norkrans  5     Manuel Romero-Gomez  6     Daniel E. Cohen  7     Thomas Podsadecki    
1 Elisabeth Hospital, Linz, Austria
2 A.o. Ospedale Niguarda Ca Granda, Milan, Italy
3 Abbvie Inc., North Chicago, United States
4 The Chaim Sheba Medical Center, Tel Hashomer, Israel
5 Sahlgrenska University Hospital, Göteborg, Sweden
6 Hospital Universitario Nuestra Senora De Valme, Seville, Spain
7 Abbvie Inc., North Chicago, United State

Conference
UEG Week 2014

Citation
United European Gastroenterology Journal; 2014: 2 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing